Moreover, the OS rate of the group with high RPS6 expression was significantly shorter than that of the group with low RPS6 expression, indicating that RPS6 levels are negatively associated with survival in patients with ovarian cancer. The gene discussed is RPS6; the disease is ovarian carcinoma.